Fundz

Avicanna secures $500,000 through a strategic non-brokered private placement, offering 3,333,334 units at $0.15 each. This investment aims to support international commercialization and pharmaceutical partnerships.

PRIVATEAug 19, 2026

Amount Raised

$500,000

Round Type

Post-IPO Equity

TorontoHealthcareHealth Care

Investors

Michael Porter

Description

Avicanna Inc. has announced the closing of a strategic non-brokered private placement. The offering raised aggregate gross proceeds of $500,000, comprising 3,333,334 units priced at $0.15 each. Each unit includes a common share and a warrant for future share purchases

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as Avicanna that raised within 45 days of this round, from Fundz verified event records.

  • Peca Labs raised $13M on September 30, 2026.
  • J3 Bioscience raised $50K on September 30, 2026.
  • Lungpacer Medical raised $7.8M on September 30, 2026.
  • Curadel Surgical Innovations raised $50M on September 18, 2026.
  • Flyte raised $520K on September 18, 2026.
  • Circle Pharma raised $93M (Series E) on September 16, 2026.

Who to call at Avicanna, and when

A new round usually means Avicanna is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Avicanna raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Avicanna, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Avicanna. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Avicanna

Location

480 UNIVERSITY AVENUE

Toronto, Ontario, Canada

About

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of cannabinoid-based products and formulations for the global medical and pharmaceutical market segments. Avicanna has an established scientific platform including R&D and clinical development leading to the commercialization of more than thirty proprietary, evidence-based finished products and supporting four commercial stage business pillars.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Avicanna raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Verified contactsAras A., Chief Executive Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Avicanna's next move

See what Strategic adds

Avicanna raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.